Ram Krishnan

Ram Krishnan is a declared insider of Ernexa Therapeutics Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 21 May 2015 to 27 August 2019, the count stands at 34 filings.

The open-market record is one-sided, with 18 purchases worth €48k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 16 share grants.

Half of the purchases are above €601 and half below. Of 17 purchases, 17 formed part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. Looking at 18 purchases old enough to measure, the stock rose over the following 90 days in 0% of cases; the median change was -23.8%. This is a record of the past, not a forecast.

Most recently, on 27 August 2019, the filings show a share grant worth €602 in Ernexa Therapeutics Inc. The latest purchase dates back some time: it was published 3,797 days ago, on 17 June 2016. Half of the filings or more reach the SEC (Form 4) feed on the day of the trade. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.